MapLight Therapeutics, Inc. Common Stock (MPLT) — Strategic Asset Allocation Index
MapLight Therapeutics, Inc. Common Stock (MPLT) has a Strategic Asset Allocation Index of 32.3% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $147.99 Million) total $147.99 Million, measured against net assets of $458.37 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check MapLight Therapeutics, Inc. Common Stock liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
MapLight Therapeutics, Inc. Common Stock Strategic Asset Allocation Index (2025–2025)
This chart shows how MapLight Therapeutics, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the index stands at 32.3%, representing strategic assets of $147.99 Million against net assets of $458.37 Million USD. See MapLight Therapeutics, Inc. Common Stock (MPLT) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for MapLight Therapeutics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for MapLight Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of MapLight Therapeutics, Inc. Common Stock.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 32.3% | $147.99 Million | $- | $147.99 Million | $458.37 Million | — |